Urteste S.A. (WSE:URT)
Poland · Delayed Price · Currency is PLN 43.60
-0.20 (-0.46%)
Aug 14, 2026, 3:53 PM CET
Urteste Market Cap
Urteste has a market cap or net worth of 66.54 million as of August 14, 2026. Its market cap has decreased by -8.88% in one year.
Market Cap
66.54M
Enterprise Value
63.55M
Revenue
2.50M
Ranking
n/a
PE Ratio
n/a
Stock Price
43.60
ChartMarket Cap Chart
Since October 27, 2021, Urteste's market cap has decreased from 110.64M to 66.54M, a decrease of -39.86%. That is a compound annual growth rate of -10.05%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 66.54M | 21.03% |
| Dec 30, 2025 | 54.98M | -59.03% |
| Dec 30, 2024 | 134.20M | -12.66% |
| Dec 29, 2023 | 153.65M | 70.57% |
| Dec 30, 2022 | 90.08M | -17.62% |
| Dec 30, 2021 | 109.35M | -1.16% |
| Oct 27, 2021 | 110.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 575.25M |
| Captor Therapeutics Spolka Akcyjna | 457.44M |
| Bioceltix | 442.58M |
| Ryvu Therapeutics | 390.73M |
| BIOTON | 328.00M |
| Synthaverse | 223.14M |
| Poltreg | 157.38M |
| Molecure | 127.12M |